Brief: Calithera Biosciences Shares Progress In Sapanisertib And Mivavotinib Clinical Programs
July 13 (Reuters) - Calithera Biosciences Inc CALA.O :
* CALITHERA BIOSCIENCES SHARES PROGRESS IN SAPANISERTIB AND
MIVAVOTINIB CLINICAL PROGRAMS AT UPCOMING LUNG CANCER AND
LYMPHOMA CONFERENCES
Source text for Eikon: ID:nGNX5SrYBb
Further company coverage: CALA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Calithera Biosciences
See all newsBrief: Calithera Biosciences Announces Update On Complete Liquidation And Dissolution
Brief: Calithera Biosciences Announces Update On Complete Liquidation And Dissolution
Brief: Calithera Biosciences Receives Notice Of Delisting Or Failure From Nasdaq
Calithera slumps as board approves company liquidation and dissolution
Brief: Calithera Biosciences Announces Board Approval Of Complete Liquidation And Dissolution